Adult S.o. Drugs

Front 1

Adenosine Indications

Back 1

Narrow complex Tachycardia

Rate >/= 160

Front 2

Adenosine SO

Back 2

1. 6mg rapid IVP; may repeat 12mg rapid IVP 1x if >160 rate persists more than 2 min

2. 12mg rapid IVP 1x as initial dose if pt reports prior conversion to this dose only

Front 3

Adenosine Form

Back 3

6mg or 12mg solution vial

Prefilled syringe

Front 4

Albuterol Form

Back 4

2.5mg/3mL solution

Front 5

Albuterol Indications

Back 5

Asthma (wheezing, stridor, smoke inhalation)

Crush injury potassium control

Front 6

Albuterol SO

Back 6

Asthma/Crush injury:

Continuous neb of 6.0mL (5mg) as tolerated

Front 7

Amiodarone Form

Back 7

50mg/1mL solution

Front 8

Amiodarone Indications

Back 8

1. Unstable wide complex tach w/ pulse

2. V-Fib/Wide complex tach w/o pulse

Front 9

Amiodarone SO

Back 9

Unstable wide tach w/ pulse:

150mg IV, may repeat 1x after 3 min

V-Fib/wide tach w/o pulse:

300mg IV/IO, may repeat 150mg 1x after 3 min

Front 10

ASA Form

Back 10

81mg tablets

Front 11

ASA Indications

Back 11

CP of suspected cardiac origin

Front 12

ASA SO

Back 12

4 tablets (324mg)

swallowed or chewed

Front 13

Atropine Form

Back 13

1mg single dose vial

Prefilled syringe

Front 14

Atropine Indications

Back 14

1. Symptomatic Bradycardia, rate < 60

2. OPP suspected

Front 15

Atropine SO

Back 15

Bradycardia:

0.5mg IV/IM, may repeat every 3 min for continued symptomatic brady to max of 3mg

OPP:

2mg IV/IM, may repeat 1x after 3 min

Front 16

Dextrose Form

Back 16

50% solution (50mL preload)

10% solution (250mL IV bag)

Front 17

Dextrose Indications

Back 17

1. Suspected hypoglycemia <80

2. Diabetic in asystole or PEA w/ suspected hypoglycemia

3. IO: Unconscious diabetic w/ hypoglycemia or UTO IV and unresponsive to IM glucagon

Front 18

Dextrose SO

Back 18

50mL IV, may repeat 1x if BGL remains <60

50mL IO 1x

250mL IV/IO infusion

Front 19

Diphenhydramine Indications

Back 19

1. Anaphylaxis; Moderate rxn

2. Dystonic rxn

Front 20

Diphenhydramine SO

Back 20

25mg IM/IV/IO 1x

Front 21

Epinephrine Form

Back 21

1:1000 solution (multi dose vial)

1:10,000 solution (prefill)

Front 22

Epinephrine 1:1000 Indications

Back 22

1. Moderate allergic rxn - hold if signs of CHF, cardiac hx, CP, age > 40

2. Wheezing consistent w/ asthma that fails to respond to Albuterol or CPAP - hold if signs of CHF, cardiac hx, CP, age > 40

3. Anaphylaxis (hypotension, severe wheezing, resp distress, impending airway obstruction)

Front 23

Epinephrine 1:10,000 Indications

Back 23

1. Anaphylaxis (hypotension, severe wheezing, resp distress, impending airway obstruction)

2. Cardiac arrest w/ VF, wide complex tach, asystole, PEA

Front 24

Epinephrine 1:1,000 SO

Back 24

0.3mg SQ/IM 1x

Front 25

Epinephrine 1:10,000 SO

Back 25

Anaphylaxis:

0.3mg IV/IO 1x

Cardiac Arrest:

1mg IV/IO, may repeat for continued VF, wide complex tach, asystole, or PEA, 3 min intervals

Front 26

Fentanyl Form

Back 26

100 mcg/2mL solution

Front 27

Fentanyl Indications

Back 27

1. Pain control for extremity trauma; burns; amputation; crush and degloving injuries; eye injury; snake envenomation; impaled object injuries

2. CP of suspected cardiac origin not relieved by NTG

Front 28

Fentanyl SO

Back 28

Pain:

100mcg IN (1mL ea nostril); may repeat 1x after 3 min for continued pain

50mcg IV/IM; may repeat 1x after 3 min

CP:

50mcg IV; may repeat 1x after 3 min

Front 29

Glucagon Form

Back 29

1mg ampule w/ dilutent

Front 30

Glucagon Indications

Back 30

Suspected hypoglycemia; <80 and unable to establish IV access

Front 31

Glucagon SO

Back 31

1mg IM 1x

Front 32

Glucose Form

Back 32

oral solution

tablets

packets

drink

Front 33

Glucose Indications

Back 33

Suspected hypoglycemia <80

Front 34

Glucose SO

Back 34

PO as tolerated if airway intact

Front 35

Lidocaine Form

Back 35

2% solution

Front 36

Lidocaine Indication

Back 36

IO infusion pain

Front 37

Lidocaine SO

Back 37

20mg IO, may repeat 1x after 3 min

Front 38

Midazolam Form

Back 38

5mg/1mL single dose vial

Front 39

Midazolam Indications

Back 39

1. SZ control

2. Extreme discomfort while pacing bradycardia; systolic BP >90

3. Behavioral emergency (incl. suspected excited delirium)

4. Suspected stimulant intoxication (agitation causing danger to self and others)

Front 40

Midazolam SO

Back 40

SZ control:

5mg IN divided between nostrils, may repeat 1x after 3 min

5mg IM, may repeat 1x after 3 min

Pacing:

5mg IN divided between nostrils, may repeat 1x after 3 min

5mg IV 1x

Behavioral/Intoxication:

5mg IM 1x

Front 41

MS Form

Back 41

4mg/1mL carpuject

10mg/1mL single dose vial

Front 42

MS Indications

Back 42

1. CP not relieved by NTG

2. Pain control for extremity trauma, burns, amputation, crush/degloving, eye injury, snake envenomation, impaled injuries

3. Crush/Burn injury w/ severe pain

Front 43

MS 4mg carpuject SO

Back 43

CP/Pain:

4mg IV, may repeat 1x after 3 min, hold if BP < 90

Crush/Burn severe Pain:

4mg IO, may repeat 1x after 3 min, hold if BP <90

(if IO already established)

Front 44

MS 10mg single dose vial SO

Back 44

CP/Pain:

5mg IV/SQ, may repeat 1x after 3 min, hold if BP < 90

Crush/Burn severe Pain:

5mg/SQ/IM IO, may repeat 1x after 3 min, hold if BP <90

(IO only if IO already established)

Front 45

Narcan Indications

Back 45

1. Narcotic OD suspected, RR </= 12/min

Front 46

Narcan SO

Back 46

0.8, 1, or 2mg IN/IM

0.4mg or 1mg IV

Repeat every 3 min as needed to maintain RR

Front 47

NTG Form

Back 47

0.4mg per dose spray or tablet

Front 48

NTG Indications

Back 48

1. CP of cardiac origin

2. Pulmonary rales/suspected CHF, BP > 100 and <150

3. Pulmonary rales/suspected CHF, BP > 150

Front 49

NTG SO

Back 49

CP:

0.4mg SL may repeat every 3 min for total of 3x

Hold if BP <90

Rales/CHF:

0.4mg SL may repeat every 3 min for total of 3x (BP >100 and <150)

0.8mg SL may repeat every 3 min for total of 3x; use 1x if BP <150

Front 50

NS Indications

Back 50

1. Hypotension/poor signs of perfusion (hypovolemia, dehydration, shock)

2. PEA/Asystole

3. Trauma full arrest; traumatic shock/hypotension; Hypotension w/ vaginal hemorrhage

4. Crush injury of major muscle group >1 hr

5. Stimulant intoxication; excited delirium

6. Narrow QRS tach w/ rate 100-150, lungs clear, > 150 w/ dehydration and lungs clear

Front 51

NS SO

Back 51

Hypotension/PEA/Asystole/Intoxication/Narrow Tach:

250mL bolus IV/IO, may repeat to total of 1L (hold if signs of CHF)

Trauma/Crush Injury:

250mL IV/IO wide open

Front 52

Zofran SO

Back 52

8mg dissolve orally

Front 53

Oxygen Indications

Back 53

1. Hypoxia; SPO2 <95%: smoke inhalation, CO toxicity, near drowning, diving accidents

2. Pt cannot tolerate mask; COPD w/ resp distress

3. Pt on chronic O2 therapy

Front 54

O2 SO

Back 54

10Lpm flow rate via mask

6Lpm NC when mask not tolerated

Maintain home O2 rate

Front 55

Sodium Bicarb Indications

Back 55

Crush injury of major muscle group > 1 hr

Front 56

Sodium Bicarb SO

Back 56

50mL prefill IV/IO 1x